dc.date.accessioned | 2022-03-26T16:29:59Z | |
dc.date.available | 2022-03-26T16:29:59Z | |
dc.date.created | 2021-12-02T12:59:57Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Sandler, Carolina X Wyller, Vegard B. B Moss-Morris, Rona Buchwald, Dedra Crawley, Esther Hautvast, Jeannine Katz, Ben Z Knoop, Hans Little, Paul Taylor, Renee Wensaas, Knut-Arne Lloyd, Andrew R . Long COVID and post-infective fatigue syndrome: A review. Open Forum Infectious Diseases. 2021, 8(10) | |
dc.identifier.uri | http://hdl.handle.net/10852/92974 | |
dc.description.abstract | Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed “long-COVID”), with up to 46% of patients reporting fatigue that lasts from weeks to months. The investigators of the international Collaborative on Fatigue Following Infection (COFFI) conducted a systematic review of post-COVID fatigue and a narrative review on fatigue after other infections, and made recommendations for clinical and research approaches to assessing fatigue after COVID-19. In the majority of COVID-19 cohort studies, persistent fatigue was reported by a significant minority of patients, ranging from 13% to 33% at 16–20 weeks post-symptom onset. Data from the prospective cohort studies in COFFI and others indicate that fatigue is also a prevalent outcome from many acute systemic infections, notably infectious mononucleosis, with a case rate for clinically significant Post-infective fatigue after exclusion of recognized medical and psychiatric causes, ranging from 10%–35% at 6 months. To better characterize post-COVID fatigue, the COFFI investigators recommend the following: application of validated screening questionnaires for case detection; standardized interviews encompassing fatigue, mood, and other symptoms; and investigative approaches to identify end-organ damage and mental health conditions. | |
dc.language | EN | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.title | Long COVID and post-infective fatigue syndrome: A review | |
dc.type | Journal article | |
dc.creator.author | Sandler, Carolina X | |
dc.creator.author | Wyller, Vegard B. B | |
dc.creator.author | Moss-Morris, Rona | |
dc.creator.author | Buchwald, Dedra | |
dc.creator.author | Crawley, Esther | |
dc.creator.author | Hautvast, Jeannine | |
dc.creator.author | Katz, Ben Z | |
dc.creator.author | Knoop, Hans | |
dc.creator.author | Little, Paul | |
dc.creator.author | Taylor, Renee | |
dc.creator.author | Wensaas, Knut-Arne | |
dc.creator.author | Lloyd, Andrew R | |
cristin.unitcode | 185,53,82,0 | |
cristin.unitname | Klinikk for indremedisin og lab fag | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.cristin | 1963401 | |
dc.identifier.bibliographiccitation | info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Open Forum Infectious Diseases&rft.volume=8&rft.spage=&rft.date=2021 | |
dc.identifier.jtitle | Open Forum Infectious Diseases | |
dc.identifier.volume | 8 | |
dc.identifier.issue | 10 | |
dc.identifier.pagecount | 7 | |
dc.identifier.doi | https://doi.org/10.1093/ofid/ofab440 | |
dc.identifier.urn | URN:NBN:no-95558 | |
dc.type.document | Tidsskriftartikkel | |
dc.type.peerreviewed | Peer reviewed | |
dc.source.issn | 2328-8957 | |
dc.identifier.fulltext | Fulltext https://www.duo.uio.no/bitstream/handle/10852/92974/1/ofab440.pdf | |
dc.type.version | PublishedVersion | |
cristin.articleid | ofab440 | |